SAMLYN CAPITAL, LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Corvus Pharmaceuticals, Inc. (CRVS)

Filing Manager: SAMLYN CAPITAL, LLC
Reporting Manager: Samlyn Capital, LLC
Security: Corvus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Symbol: CRVS
Shares outstanding: 68M shares
Disclosed Ownership: 6.67M shares
Ownership: 9.8%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 01:53 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Samlyn Capital, LLC	9.8%	6.67M	6.67M	By: Samlyn, LP, its sole member, By: Samlyn GP, LLC, its general partner, By: /s/ Robert Pohly	Robert Pohly/Managing Member*
Samlyn, LP	9.8%	6.67M	6.67M	By: Samlyn GP, LLC, its general partner, By: /s/ Robert Pohly	Robert Pohly/Managing Member*
Robert Pohly	9.8%	6.67M	6.67M	By: /s/ Robert Pohly	Robert Pohly*